TMR-031020
Repaglinide EP Impurity C
(S)-3-Methyl-1-(2-(1-piperidinyl)phenyl)butylamine;Repaglinide;(s)-3-methyl-1-(2-piperidineophenyl)-1-butylamine;(S)-3-Methyl-1-[2-(1-piperidinyl) phenyl]butylamine;(S)-3-Methyl-1-(2-(piperidin-1-yl)phenyl)butan-1-amine;(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butan-1-amine;(S)-3-Methyl-1-(2-piperidin-1-yl phenyl)butylamine;(S)-3-METHYL-1-(2-PIPERIDIN-1-YL-PHENYL)BUTYLAMINE;Benzenemethanamine,a-(2-methylpropyl)-2-(1-piperidinyl)-,(S)-;(1S)-3-Methyl-1-[2-(piperidin-1-yl)phenyl]butan-1-amine;(S)-3-Methyl-1-(2-piperidinophenyl)-1-butylamine;Repaglinide intermediate 4;Repaglinide Intermediate 1;(S)-3-Methyl-1-(2-piperidin-1-ylphenyl)butylamin;(S)-3-Methyl-1-(2-piperidin-1-ylphenyl)butylamine;(S)-3-METHYL-1-[2-(1-PIPERIDINYL)PHENYL]-BUTYLAMINE;(S)-3-Methyl-1-(2-piperidine-1-yl-phenyl)-butylamine;(1S)-3-Methyl-1-[2-(piperidin-1-yl)phenyl]butan-1-aMine;(S)-3-Methyl-1-(2-piperidin-1-ylphenyl)butylamine, >=99%;(S)-[A-(2-methylpropyl)-2-(1-piperidinyl)benzene-methanamine;(αS)-α-(2-Methylpropyl)-2-(1-piperidinyl)-benzenemethanamine
Open
147769-93-5
C16H26N2
246.40